Wessel Willem Fuijkschot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wessel Willem Fuijkschot has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Hans W. M. Niessen
Department of Pathology and Department of Cardiac Surgery, Institute for Cardiovascular Research, Amsterdam University Medical Center, 1007 MB Amsterdam, Netherlands
3 shared publications - Paul A. J. Krijnen
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
3 shared publications Yvo M. Smulders
Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands; Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, Amsterdam, the Netherlands
3 shared publications- Abel Thijs
Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication Alexander B. A. Vonk
Department of Cardiac Surgery, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication- Alexandra Vera Ruth van Reuler
Department of Obstetrics and Gynecology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 1 January 2017
- Published by Elsevier in Journal of Cardiology
- Vol. 69 (1) , 394-400
Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction
- 1 January 2017
- Published by Elsevier in Journal of Cardiology
- Vol. 69 (1) , 394-400
Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction
- Open Access
- 1 December 2016
- Published by Elsevier in Atherosclerosis
- Vol. 255, 164-170
Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE−/− mice
- 1 December 2016
- Published by Elsevier in Atherosclerosis
- Vol. 255, 164-170
Open AccessOrthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE−/− mice
- 1 October 2016
- Published by Elsevier in Pregnancy Hypertension
- Vol. 6 (4) , 350-355
Aspirin adherence during high-risk pregnancies, a questionnaire study
- 1 October 2016
- Published by Elsevier in Pregnancy Hypertension
- Vol. 6 (4) , 350-355
Aspirin adherence during high-risk pregnancies, a questionnaire study
- 3 March 2016
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 46 (4) , 334-341
Prevention of age‐induced N(ε)‐(carboxymethyl)lysine accumulation in the microvasculature
Objective: N(ε)‐(carboxymethyl)lysine (CML) is one of the major advanced glycation end products in both diabetics and nondiabetics. CML depositions in the microvasculature have recently been linked to the aetiology of acute myocardial infarction and cognitive impairment in Alzheimer's disease, possibly related to local enhancement of inflammation and oxidative processes. We hypothesized that CML deposition in the microvasculature of the heart and brain is age‐induced and that it could be inhibited by a diet intervention with docosahexaenoic acid (DHA), an omega‐3 fatty acid known for its anti‐inflammatory and antioxidative actions.Materials and methods: ApoE−/− mice (n = 50) were fed a Western diet and were sacrificed after 40, 70 and 90 weeks. Part of these mice (n = 20) were fed a Western diet enriched with DHA from 40 weeks on. CML in cardiac and cerebral microvessels was quantified using immunohistochemistry.Results: Cardiac microvascular depositions of CML significantly increased with an immunohistochemical score of 11·85 [5·92–14·60] at 40 weeks, to 33·17 [17·60–47·15] at 70 weeks (P = 0·005). At the same time points, cerebral microvascular CML increased from 6·45; [4·78–7·30] to 12·99; [9·85–20·122] (P = 0·003). DHA decreased CML in the intramyocardial vasculature at both 70 and 90 weeks, significant at 70 weeks [33·17; (17·60–47·15) vs. 14·73; (4·44–28·16) P = 0·037]. No such effects were found in the brain.Conclusions: Accumulation of N(ε)‐(carboxymethyl)lysine in the cerebral and cardiac microvasculature is age‐induced and is prevented by DHA in the intramyocardial vessels of ApoE−/− mice.
- 3 March 2016
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 46 (4) , 334-341
Prevention of age‐induced N(ε)‐(carboxymethyl)lysine accumulation in the microvasculature
Objective: N(ε)‐(carboxymethyl)lysine (CML) is one of the major advanced glycation end products in both diabetics and nondiabetics. CML depositions in the microvasculature have recently been linked to the aetiology of acute myocardial infarction and cognitive impairment in Alzheimer's disease, possibly related to local enhancement of inflammation and oxidative processes. We hypothesized that CML deposition in the microvasculature of the heart and brain is age‐induced and that it could be inhibited by a diet intervention with docosahexaenoic acid (DHA), an omega‐3 fatty acid known for its anti‐inflammatory and antioxidative actions.Materials and methods: ApoE−/− mice (n = 50) were fed a Western diet and were sacrificed after 40, 70 and 90 weeks. Part of these mice (n = 20) were fed a Western diet enriched with DHA from 40 weeks on. CML in cardiac and cerebral microvessels was quantified using immunohistochemistry.Results: Cardiac microvascular depositions of CML significantly increased with an immunohistochemical score of 11·85 [5·92–14·60] at 40 weeks, to 33·17 [17·60–47·15] at 70 weeks (P = 0·005). At the same time points, cerebral microvascular CML increased from 6·45; [4·78–7·30] to 12·99; [9·85–20·122] (P = 0·003). DHA decreased CML in the intramyocardial vasculature at both 70 and 90 weeks, significant at 70 weeks [33·17; (17·60–47·15) vs. 14·73; (4·44–28·16) P = 0·037]. No such effects were found in the brain.Conclusions: Accumulation of N(ε)‐(carboxymethyl)lysine in the cerebral and cardiac microvasculature is age‐induced and is prevented by DHA in the intramyocardial vessels of ApoE−/− mice.